GUIDELINES ON THE REVISED INTERNATIONAL CONVERGENCE OF CAPITAL MEASUREMENT AND CAPITAL STANDARDS FOR BOTSWANA
PILLAR III DISCLOSURE FOR 31 DEC 2016
(d)The Disclosure Templates(Extract from Basel II Guidelines)
12.18A bank shall, at a minimum, disclose the information as set out in the Disclosure Templates below. In order to ensure comparability of these templates amongst different jurisdictions, a bank should not add, delete or change the definition of any row in the templates and to report a value of zero for the line items that are not applicable, such as capital buffers, that are not yet implemented in Botswana. The only, exception relates to the expansion of rows as under Table 26, for reconciliation purposes. The disclosure templates cover the following main areas:
(i)Regulatory Capital Requirements
12.19Tables 22 and 24 are designed to capture the capital positions of a bank in terms of capital structure and capital adequacy, respectively, whereas Table 23 gives explanations of each row in Table 22. In addition, Tables 28 and 29 provides the main features of the regulatory capital instruments and explanation of each feature, respectively.
12.20A bank should further disclose a full reconciliation of all regulatory capital elements under Table 21, back to the balance sheet in the audited financial statements, through the following steps:
Step 1:Disclose the reported balance sheet under the regulatory scope of consolidation (refer to Table 25). Disclose how the balance sheet in the published financial statements changes when the regulatory scope of consolidation is applied. If identical, a bank should state that there is no difference between the regulatory consolidation and accounting consolidation, and move to step 2 below. In addition, a bank is required to disclose the list of the legal entities that are included within the accounting scope of consolidation, but excluded from the regulatory scope of consolidation and vice versa. If some entities are included in both the regulatory scope of consolidation and accounting scope of consolidation, but the method of consolidation differs between these two scopes, a bank is required to list these legal entities separately, and explain the differences in the consolidation methods.
Step 2: Many of the elements used in the calculation of regulatory capital cannot be readily identified from the face of the balance sheet. Therefore, a bank should expand the lines of the balance sheet under the regulatory scope of consolidation to display all the components that are used in the composition of capital disclosure template (Table 26), and assign a reference number to the components.
Step 3: Map each of the components that are disclosed in step 2 above to the composition of capital disclosure template (Table 27)
(ii)Risk Management Processes
12.21Consistent with the International Financial Reporting Standards, a bank must disclose both the quantitative and qualitative aspects of each separate risk area (e.g; credit risk, market risk, operational risk, interest rate risk in the banking book and equity risk). In describing its risk management objectives and policies, a bank must include:
- Strategies and processes for managing those risks;
- The structure and organisation of the relevant risk management function, including the title or position of Board and senior management official that oversees risk management;
- The scope and nature of risk reporting and measurement systems;
- Policies for hedging and mitigating risks, strategies and processes for monitoring the continuing effectiveness of hedges and mitigants; and
- A general description of the internal capital adequacy assessment process, as specified under Pillar II, including a description of the methodologies used.
12.22Furthermore, a bank shall disclose additional information for the different risks, as described under Tables 30 - 36.
(iii)Remuneration
12.23Additional Pillar III disclosure requirements on remuneration cover the main components of sound compensation practices. As a result, a bank is required to disclose qualitative and quantitative information about its remuneration practices, and policies as per Tables 38 and 38 (a) covering the following:
- The governance/committee structures;
- The design or operation of the remuneration and structure, frequency of review;
- The independence of remuneration for risk/compliance staff;
- The risk adjustment methodologies;
- The link between remuneration and performance;
- The long-term performance measures (deferral, claw back); and
- The types of remuneration (cash/equity, fixed/variable).
Table 21
Scope of application
Qualitative Disclosures / (a) / The name of a bank in the group to which this Framework applies.: BANK SBI BOTSWANA LTD, GABORONE, BOTSWANA.
(b) / An outline of the difference in the basis of consolidation for accounting and regulatory purposes, within the group (a) that are fully consolidated. (b) that are pro-rata consolidated; (c) that are given a deduction treatment, and (d) equity accounted.
: SINGLE ENTITY –NO SUBSIDIARIES
(c) / Any restrictions, or other major impediments, on the transfer of funds or regulatory capital within the group.
: NOT APPLICABLE- NO SUBSIDIARIES
Quantitative Disclosures / (d) / The aggregate amount of capital deficiencies in all subsidiaries, that are not included in the consolidation for regulatory purposes (i.e., that are deducted) and the name (s) of such subsidiaries.
: NOT APPLICABLE- NO SUBSIDIARIES
(e) / The aggregate amounts (e.g., current book value) of a bank’s total interests insurance entities, which are risk-weighted, rather than deducted from capital, as well as their names, their country of incorporation or residence, the proportion of ownership interest and, if different, the proportion of voting power in these entities.
: NONE
Table 22
Common Equity Tier I capital: instruments and reserves1 / Directly issued qualifying common share (and equivalent for non-joint stock companies) capital plus related stock surplus. / 124 852
2 / Retained earnings / (16 259)
3 / Accumulated other comprehensive income (and other reserves)
4 / Directly issued capital subject to phase out from CET1 CAPITAL (only applicable to non-joint stock companies) / -
5 / Common share capital issued by subsidiaries and held by third parties (amount allowed in group CET1 CAPITAL) / -
6 / Common Equity Tier I capital before regulatory adjustments / -
Common Equity Tier I capital: regulatory adjustments
7 / Prudential valuation adjustments / -
8 / Goodwill (net of related tax liability) / -
9 / Other intangibles other than mortgage-servicing rights (net of related tax liability) / -
10 / Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability) / ( 2 931)
11 / Cash-flow hedge reserve / -
12 / Shortfall of provisions to expected losses / -
13 / Securitisation gain on sale (as set out in paragraph 562 of Basel II framework) / -
14 / Gains and losses due to changes in own credit risk on fair valued liabilities / -
15 / Defined-benefit pension fund net assets / -
16 / Investments in own shares (if not already netted off paid-in capital on reported balance sheet) / -
17 / Reciprocal cross-holdings in common equity / -
18 / Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the bank does not own more than 10% of the issued share capital (amount above 10% threshold) / -
19 / Significant investments in the common stock of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions (amount above 10% threshold) / -
20 / Mortgage servicing rights (amount above 10% threshold) / -
21 / Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability) / -
22 / Amount exceeding the 15% threshold / -
23 / of which: significant investments in the common stock of financials / -
24 / of which: mortgage servicing rights / -
25 / of which: deferred tax assets arising from temporary differences / -
26 / National specific regulatory adjustments / -
27 / Regulatory adjustments applied to Common Equity Tier I due to insufficient Additional Tier I and Tier II to cover deductions / -
28 / Total regulatory adjustments to Common equity Tier I
29 / Common Equity Tier I capital (CET1 CAPITAL) / 105 662
Additional Tier I capital: instruments
30 / Directly issued qualifying Additional Tier I instruments plus related stock surplus / 0
31 / of which: classified as equity under applicable accounting standards / 0
32 / of which: classified as liabilities under applicable accounting standards / 0
33 / Directly issued capital instruments subject to phase out from Additional Tier I / 0
34 / Additional Tier I instruments (and CET1 CAPITAL instruments not included in row 5) issued by subsidiaries and held by third parties (amount allowed in group AT1) / 0
35 / of which: instruments issued by subsidiaries subject to phase out / 0
36 / Additional Tier I capital before regulatory adjustments / 0
37 / Investments in own Additional Tier I instruments
38 / Reciprocal cross-holdings in Additional Tier I instruments
Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the bank does not own more than 10% of the issued common share capital of the entity (amount above 10% threshold)
39
40 / Significant investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation (net of eligible short positions)
41 / National specific regulatory adjustments
42 / Regulatory adjustments applied to Additional Tier I due to insufficient Tier II to cover deductions
43 / Total regulatory adjustments to Additional Tier I capital
44 / Additional Tier I capital (AT1)
45 / Tier I capital (T1 = CET1 CAPITAL + AT1)
Tier II capital: instruments and provisions
46 / Directly issued qualifying Tier II instruments plus related stock surplus
47 / Directly issued capital instruments subject to phase out from Tier II
48 / Tier II instruments (and CET1 CAPITAL and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties (amount allowed in group Tier II)
49 / of which: instruments issued by subsidiaries subject to phase out
50 / Provisions / 804
51 / Tier II capital before regulatory adjustments
Tier II capital: regulatory adjustments
52 / Investments in own Tier II instruments / -
53 / Reciprocal cross-holdings in Tier II instruments / -
Investments in the capital of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions, where the bank does not own more than 10% of the issued common share capital of the entity (amount above the 10% threshold). / -
54
55 / Significant investments in the capital banking, financial and insurance entities that are outside the scope of regulatory consolidation (net of eligible short positions). / -
56 / National specific regulatory adjustments / -
Unpublished Current Year's Profits / 224
57 / Total regulatory adjustments to Tier II capital / -
58 / Tier II capital (T2) / 1028
59 / Total capital (TC = T1 + T2) / 106,690
60 / Total risk-weighted assets / 325,684
Capital ratios and buffers
61 / Common Equity Tier I (as a percentage of risk weighted assets) / 32.44%
62 / Tier I (as a percentage of risk-weighted assets) / 32.44%
63 / Total capital (as a percentage of risk weighted assets) / 32.75%
64 / Institution specific buffer requirement (minimum CET1 CAPITAL requirement plus capital conservation buffer plus countercyclical buffer requirements plus G-SIB buffer requirement, expressed as a percentage of risk weighted assets) / 0
65 / of which: capital conservation buffer requirement
66 / of which: bank specific countercyclical buffer requirement / 0
67 / of which: G-SIB buffer requirement / 0
68
Common Equity Tier I available to meet buffers (as a percentage of risk weighted assets)
National minima (if different from Basel III) / National Common Equity Tier I minimum ratio (if different from Basel III minimum) / 0
70 / National Tier I minimum ratio (if different from Basel III minimum) / 0
71 / National total capital minimum ratio (if different from Basel III minimum) / 0
Amounts below the thresholds for deduction (before risk-weighting) / 0
72 / Non-significant investments in the capital of other financials / 0
73 / Significant investments in the common stock of financials / 0
74 / Mortgage servicing rights (net of related tax liability) / 0
75 / Deferred tax assets arising from temporary differences (net of related tax liability) / 0
Applicable caps on the inclusion of provisions in Tier II / 0
76 / Provisions eligible for inclusion in Tier II in respect of exposures subject to standardised approach (prior to application of cap) / 0
77 / Cap on inclusion of provisions in Tier II under standardised approach / 0
78 / Provisions eligible for inclusion in Tier II in respect of exposures subject to internal ratings-based approach (prior to application of cap) / 0
79 / Cap for inclusion of provisions in Tier II under internal ratings-based approach
Capital instruments subject to phase-out arrangements (only applicable between 1 Jan 2015 and 1 Jan 2020) / 0
80 / Current cap on CET1 CAPITAL instruments subject to phase out arrangements / 0
81 / Amount excluded from CET1 CAPITAL due to cap (excess over cap after redemptions and maturities) / 0
82 / Current cap on AT1 instruments subject to phase out arrangements / 0
83 / Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities) / 0
84 / Current cap on T2 instruments subject to phase out arrangements / 0
85 / Amount excluded from T2 due to cap (excess over cap after redemptions and maturities) / 0
Table 24
Capital Adequacy
Qualitative Disclosures / (a) / A summary discussion of a bank’s approach to assessing the adequacy of its capital to support current and future activities. / Adequacy of capital has been assessed based on current Basel directives. Additional Capital of USD 5.00 Mio equivalent infused on 16.06.2016 to support future requirements.Quantitative Disclosures / (b) / Capital requirements for credit risk:
- Portfolios subject to the standardised approach, disclosed separately for each portfolio;
(d) / Capital requirements for market risk
- Standardised Measurement Approach;
- Internal models approach – Trading book.
(e) / Capital requirements for operational risk
- Basic indicator approach;
- Standardised approach;
(f) / Total and Tier I capital ratio; / 32.44%
Table 25
Balance sheet as in published financial statements / Under regulatory scope of consolidation
As at period end / As at period end
Assets
Cash and balances at central banks / 23200
Items in the course of collection from other banks / 239518
Trading portfolio assets
Financial assets designated at fair value
Derivative financial instruments
Loans and advances to banks
Loans and advances to customers / 173409
Reverse repurchase agreements and other similar / 11988
secured lending
Available for sale financial investments
Current and deferred tax assets / 2 931.00
Prepayments, accrued income and other assets / 115.00
Investments in associates and joint ventures
Goodwill and intangible assets
Property, plant and equipment / 2660.00
Total assets / 453 821
Liabilities
Deposits from banks
Items in the course of collection due to other banks
Customer accounts / 278 606
Repurchase agreements and other similar secured / 64 103
borrowing
Trading portfolio liabilities
Financial liabilities designated at fair value
Derivative financial instruments
Debt securities in issue
Accruals, deferred income and other liabilities / 1405
Current and deferred tax liabilities
Subordinated liabilities
Provisions / 890
Retirement benefit liabilities
Total liabilities / 453 821
Shareholders' Equity
Paid-in share capital / 124 852
Retained earnings / -16259
Accumulated other comprehensive income / 224
Total shareholders' equity / 108817
Table 26
Expanded Regulatory Balance Sheet
Balance sheet as in published financial statements / Under regulatoryscope of consolidation
Reference
As at period end / As at period end
Assets
Cash and balances at central banks / 23200
Items in the course of collection from other banks / 239518
Trading portfolio assets / 0
Financial assets designated at fair value / 0
Derivative financial instruments / 0
Loans and advances to banks / 0
Loans and advances to customers / 173409
Reverse repurchase agreements and other similar secured lending / 11988
Available for sale financial investments / 0
Current and deferred tax assets / 2931
Prepayments, accrued income and other assets / 115
Investments in associates and joint ventures
Goodwill and intangible assets
of which goodwill / 0
of which other intangibles (excluding MSRs)
of which MSRs
Property, plant and equipment / 2260
Total assets / 453 821
Liabilities
Deposits from banks / 0
Items in the course of collection due to other banks / 0
Customer accounts / 278 606
Repurchase agreements and other similar secured borrowing / 0
Trading portfolio liabilities / 0
Financial liabilities designated at fair value / 0
Derivative financial instruments / 0
Debt securities in issue / 0
Accruals, deferred income and other liabilities / 1405
Current and deferred tax liabilities
Of which DTLs related to goodwill / d
Of which DTLs related to intangible assets / e
(excluding MSRs)
Of which DTLs related to MSRs / f
Subordinated liabilities
Provisions / 890
Retirement benefit liabilities
Total liabilities / 453 821
Shareholders' Equity
Paid-in share capital / 124 852
of which amount eligible for CET1 CAPITAL / 124 852 / h
of which amount eligible for AT1 / i
Retained earnings / -16259
Accumulated other comprehensive income / 224
Total shareholders' equity / 108 817
Table 27
Extract of Basel III common disclosure template (with added column)
Common Equity Tier I capital: instruments and reserves
Component of regulatory capital reported / Source based on Reference numbers/letters of the balance sheet under the regulatory scope of consolidation from step 2.
by bank
1 / Directly issued qualifying common share (and equivalent for non-joint stock / 124 852
Companies) capital plus related stock surplus.
2 / Retained earnings / (16 259)
3 / Accumulated other comprehensive income (and other reserves) / 1028
4 / Directly issued capital subject to phase out from CET1 CAPITAL (only applicable to non- joint stock companies) / -
5 / Common share capital issued by subsidiaries and held by third parties (amount) allowed in group CET1 CAPITAL) / -
6 / Common Equity Tier I capital before regulatory adjustments / 108 817
7 / Prudential valuation adjustments / -
8 / Goodwill (net of related tax liability) / 2 931
Table 28
Main features template
1 / Issuer / BANK SBI BOTSWANA LTD.2 / Uniqueidentifier(e.g.CUSIP,ISINorBloombergidentifierforprivateplacement) / NA
3 / Governinglaw(s)oftheinstrument / Bank of Botswana
Regulatorytreatment
4 / TransitionalBaselIIIrules / Common Equity Tier I
5 / Post-transitionalBaselIIIrules / Common Equity Tier I
6 / Eligibleatsolo/group/group and solo / SOLO
7 / Instrumenttype(typestobespecifiedbyeachjurisdiction) / Common Equity Tier I
8 / Amountrecognisedinregulatorycapital(Currencyinmil,asofmostrecentreportingdate) / P 124.851 Mio
9 / Parvalueofinstrument / P 1 each
10 / Accountingclassification / Tier I Paid Up Capital
11 / Originaldateofissuance / 22.12.12: P 25 Mio
12 / Perpetualordated / perpetual
13 / Originalmaturitydate / NA
14 / Issuercallsubjecttopriorsupervisoryapproval / NA
15 / Optionalcalldate,contingentcalldatesandredemptionamount / NA
16 / Subsequentcalldates,ifapplicable / NA
Coupons/ dividends
17 / Fixedorfloatingdividend/coupon / NA
18 / Couponrateandanyrelatedindex / NA
19 / Existenceofa dividendstopper / NA
20 / Fullydiscretionary,partiallydiscretionaryormandatory / NA
21 / Existenceofstepuporotherincentivetoredeem / NA
22 / Noncumulativeorcumulative / NA
23 / Convertibleornon-convertible / NA
24 / Ifconvertible,conversiontrigger(s) / NA
25 / Ifconvertible,fullyor partially / NA
26 / Ifconvertible,conversionrate / NA
27 / Ifconvertible,mandatoryor optionalconversion / NA
28 / Ifconvertible,specifyinstrumenttypeconvertibleinto / NA
29 / Ifconvertible,specifyissuerofinstrumentitconvertsinto / NA
30 / Write-downfeature
31 / If write-down,write-downtrigger(s) / NA
32 / If write-down,fullorpartial / NA
33 / If write-down,permanentortemporary / NA
34 / Iftemporarywrite-down,descriptionof write-upmechanism / NA
35 / Positioninsubordinationhierarchyinliquidation(specifyinstrumenttypeimmediatelyseniorto instrument) / NA
36 / Non-complianttransitionedfeatures / NA
37 / If yes,specifynon-compliantfeatures / NA
1